Camel milk-derived small molecule peptide and its application
The preparation of small molecule peptide Pro-Phe-Pro-Met-Trp-Thr-Phe-Leu-Ser-Arg by fermenting camel milk solves the side effect problem of chemically synthesized DPP-IV inhibitors, achieving highly efficient inhibition of dipeptidyl peptidase IV activity and improvement of diabetic cell function, and is suitable for functional foods and health products.
Patent Information
- Application Number
- CN202310089954.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-02-09
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2043-02-09
AI Technical Summary
Existing chemically synthesized DPP-IV inhibitors have side effects when used to treat type 2 diabetes, and the development of food-derived DPP-IV inhibitors has not fully utilized the potential of dairy-derived substances.
The small molecule peptide Pro-Phe-Pro-Met-Trp-Thr-Phe-Leu-Ser-Arg was prepared by fermenting camel milk and used to prepare dipeptidyl peptidase IV inhibitors. The peptide sequence with high inhibitory activity was obtained through multi-step purification and identification, and a suitable dosage form was prepared.
Small molecule peptides significantly inhibit dipeptidyl peptidase IV activity and improve high glucose-induced insulin resistance in Hepg2 cells, providing a safe and effective hypoglycemic mechanism, suitable for the preparation of functional foods and health products.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Citation Information
Patent Citations
Gly-Pro-type peptide with DPP-IV inhibitory activity and application thereof
CN114349819A
Tartary buckwheat active peptide as well as preparation method and new application thereof
CN115010787A
Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use
US20090075904A1
